The syntheses of a cobalt(III) complex, 2, containing N-(2-pyridylmethyl)urea and of six complexes, 3, containing phenyl-substituted N-2-pyridylmethyl-N'-(X)phenylureas (where X = 4-H, 4-CH(3), 4-Br, 3-Cl, 4-CF(3), and 4-NO(2)), have been accomplished by reaction of [(en)(2)Co(OSO(2)CF(3))(2)](CF(3)SO(3)) with the urea ligands in tetramethylene sulfone. The complexes have been characterized by UV-vis, FTIR, (1)H NMR, and (13)C NMR spectra along with elemental analysis. Also, X-ray crystallographic analysis of 2 confirms that the urea ligand chelates as a bidentate through the pyridyl nitrogen atom and the endo deprotonated, urea nitrogen atom to form a stable five-membered ring. Crystals of the perchlorate salt of 2 were monoclinic, space group P2(1)/c with a = 9.743(1) Å, b = 13.924(3) Å, c = 15.006(4) Å, beta = 97.07(1) degrees, and Z = 4. Reflection data (3454) with I = 3sigma(I) were refined to conventional R factors of 0.037 and 0.051. In acidic solution (0.05-1.00 M HCl at 55 degrees C), the phenyl-substituted complexes undergo hydrolysis to form the bis(ethylenediamine)(2-picolylamine-N,N')cobalt(III) ion, 4, aniline, and CO(2). The hydrolysis kinetics of the phenyl-substituted complexes were studied by UV-vis spectroscopy (I = 1.00 M HCl/LiCl). At 55 degrees C the observed rate constants fit the rate law k(obsd) = kK[H(+)]/(1 + K[H(+)]). It is proposed that the protonated urea eliminates aniline to give a coordinated isocyanate intermediate that hydrolyzes rapidly to the pyridyl methylamine complex and CO(2) via the carbamate complex. Since all of the studies of this kind to date appear to involve the NCO intermediate, it raises the prospect that urease also functions by a similar path and that urease should be tested with NCO(-) as a substrate.

Most ocular surgical procedures take approximately 60 min to complete, the anaesthetic property of the safest drug, tetracaine, is initiated in a few minutes and lasts approximately 10-15 min. The purpose of the present study was to develop an ocular tetracaine formulation which can produce an immediate onset of action and/or longer duration of action during the entire surgical procedure. Tetracaine-loaded microparticle formulation was prepared by the method of spray-drying and characterized in terms of size, zeta potential, morphology, thermal stability and release pattern. The study reports a microparticulate ocular formulation with minimum cytotoxicity and optimum cellular uptake. In addition, microencapsulated tetracaine was found to significantly increase the duration of action of the drug up to 4-fold. Taken together, the results presented in this work described albumin-chitosan microparticles to be an effective delivery platform for ocular anaesthetic agents and a potential treatment of various ocular diseases.

The purpose of this study was to evaluate the possibility of lectin-coupled microspheres to improve the targeted delivery of protein antigens to the lymphoid tissues of mucosal surfaces. Bovine serum albumin containing acid phosphatase model protein and polystyrene microspheres were coupled with mouse M-cell-specific Ulex europaeus lectin. The coupling efficiency, physical characteristics and the binding capabilities of the microspheres to the follicle associated epithelium of the Peyer's patches were evaluated in vitro and ex vivo in mice intestine. The results showed that coupling of lectin to albumin microspheres did not significantly affect the bioactivity of the encapsulated acid phosphatase model protein. It was also shown that there was preferential binding of the lectin-coupled microspheres to the follicle-associated epithelium. It was concluded from the results of the study that coupling of ligands such as lectin specific to cells of the follicle associated epithelium can increase the targeting of encapsulated candidate antigens for delivery to the Peyer's patches of the intestine for improved oral delivery.